Symptomatic, biochemical and radiographic recovery in patients with COVID-19. Issue 1 (7th April 2021)

• Record Type: Journal Article
• Authors: Mallia, Patrick; Meghji, Jamilah; Wong, Brandon; Kumar, Kartik; Pilkington, Victoria; Chhabra, Shaan; Russell, Ben; Chen, Jian; Srikanthan, Karthikan; Park, Mirae; Owles, Harriet; Liew, Felicity; Alcada, Joana; Martin, Laura; Coleman, Meg; Elkin, Sarah; Ross, Clare; Agrawal, Shweta; Gardiner, Thomas; Bell, Aaron; White, Alice; Hampson, Dominic; Vithlani, Gauri; Manalan, Kavina; Bramer, Solange; Martin Segura, Alejandra; Kucheria, Anushree; Ratnakumar, Prashanthi; Sheeka, Alexander; Anandan, Lavanya; Copley, Susan; Russell, Georgina; Bloom, Chloe I; Kon, Onn Min;
• Is Part Of: BMJ open respiratory research. Volume 8:Issue 1(2021)
• Publication Date: 2021-04-07
• Subjects: COVID-19; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Diseases -- Treatment -- Periodicals; Respiratory therapy -- Periodicals; 616.2005
• DOI: 10.1136/bmjresp-2021-000908
• Languages: English
• ISSNs: 2052-4439

Abstract

Abstract : Background: The symptoms, radiography, biochemistry and healthcare utilisation of patients with COVID-19 following discharge from hospital have not been well described. Methods: Retrospective analysis of 401 adult patients attending a clinic following an index hospital admission or emergency department attendance with COVID-19. Regression models were used to assess the association between characteristics and persistent abnormal chest radiographs or breathlessness. Results: 75.1% of patients were symptomatic at a median of 53 days post discharge and 72 days after symptom onset and chest radiographs were abnormal in 47.4%. Symptoms and radiographic abnormalities were similar in PCR-positive and PCR-negative patients. Severity of COVID-19 was significantly associated with persistent radiographic abnormalities and breathlessness. 18.5% of patients had unscheduled healthcare visits in the 30 days post discharge. Conclusions: Patients with COVID-19 experience persistent symptoms and abnormal blood biomarkers with a gradual resolution of radiological abnormalities over time. These findings can inform patients and clinicians about expected recovery times and plan services for follow-up of patients with COVID-19.